s6y
Company name or ticker
Search
STEINMETZ MICHAEL
4
Somaxon Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
Filed
Thursday, June 21, 2012
Period
Jun 19, 2012
Accession number
0001209191-12-034920
Documents
FORM 4 SUBMISSION
4
FORM 4 SUBMISSION
4
On sec.gov
Filing index
All files
Complete submission text
SGML header